AllianceBernstein’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,801
| Closed | -$48.6K | – | 3311 |
|
|
2024
Q1 | $48.6K | Hold |
2,801
| – | – | ﹤0.01% | 3091 |
|
|
2023
Q4 | $43.8K | Sell |
2,801
-272
| -9% | -$4.25K | ﹤0.01% | 3138 |
|
|
2023
Q3 | $152K | Buy |
3,073
+451
| +17% | +$22.3K | ﹤0.01% | 3005 |
|
|
2023
Q2 | $205K | Buy |
2,622
+687
| +36% | +$53.7K | ﹤0.01% | 2975 |
|
|
2023
Q1 | $175K | Buy |
1,935
+239
| +14% | +$21.7K | ﹤0.01% | 2942 |
|
|
2022
Q4 | $200K | Buy |
1,696
+457
| +37% | +$53.9K | ﹤0.01% | 3009 |
|
|
2022
Q3 | $225K | Buy |
1,239
+74
| +6% | +$13.4K | ﹤0.01% | 2971 |
|
|
2022
Q2 | $105K | Buy |
1,165
+195
| +20% | +$17.6K | ﹤0.01% | 3116 |
|
|
2022
Q1 | $151K | Hold |
970
| – | – | ﹤0.01% | 3040 |
|
|
2021
Q4 | $289K | Sell |
970
-1,484
| -60% | -$442K | ﹤0.01% | 2944 |
|
|
2021
Q3 | $1.41M | Sell |
2,454
-55,552
| -96% | -$32M | ﹤0.01% | 2347 |
|
|
2021
Q2 | $26.3M | Buy |
58,006
+10,189
| +21% | +$4.63M | 0.01% | 823 |
|
|
2021
Q1 | $25.7M | Buy |
47,817
+3,399
| +8% | +$1.83M | 0.01% | 837 |
|
|
2020
Q4 | $39.3M | Buy |
44,418
+2,734
| +7% | +$2.42M | 0.02% | 649 |
|
|
2020
Q3 | $26.4M | Buy |
+41,684
| New | +$26.4M | 0.01% | 714 |
|